The Use of Central Laboratories and Remote Electronic Data Capture to Risk-Adjust Therapy for Pediatric Acute Lymphoblastic Leukemia and Neuroblastoma

Seminars in Oncology

Volumn 37, Issue 1, 2010, Pages 53-59

  Devidas, Meenakshi ^a,b   London, Wendy B ^a,c   Anderson, James R ^a,d  

^a Department of Clinical and Health Psychology   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CLINICAL PROTOCOL; ELECTRONIC MEDICAL RECORD; HIGH RISK POPULATION; HUMAN; INFORMATION RETRIEVAL; INTERNET; MEDICAL INFORMATICS; MEDICAL INFORMATION SYSTEM; NEUROBLASTOMA; OUTCOMES RESEARCH; PATIENT CODING; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AUTOMATIC DATA PROCESSING; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LABORATORIES; NEUROBLASTOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 76749112823     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2009.12.007     Document Type: Article

References (4)

1. Schultz K.R., Pullen J., Sather H., et al. Biology-driven classification of childhood acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 109 (2007) 926-935
2. Strother D, London WB, Yap J, et al. Surgery and restricted use of chemotherapy as treatment of low-risk neuroblastoma: preliminary results of Children's Oncology Group protocol 9641. Proceedings of the 38th Congress of the International Society of Paediatric Oncology.
3. Baker DL, Schmidt M, Cohn S, et al. A phase III trial of biologically-based therapy reduction for intermediate risk neuroblastoma [abstract 9504]. 2007 American Society of Clinical Oncology Annual Meeting Proceedings. Part I. 25:18S.
4. Kreissman SG, Villablanca JG, Diller L, et al. Response and toxicity to a dose-intensive multi-agent chemotherapy induction regimen for high risk neuroblastoma (HR-NB): a Children's Oncology Group (A3973) study [abstract 9505]. 2007 American Society of Clinical Oncology Annual Meeting Proceedings. Part I. 25:18S.